Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
358 pending office actions • 150 clients • 296 examiners • 110 art units • 0 of 358 (0%) have an AI response strategy ready
Casimir Jones, S.C. manages 295 pending office actions within the Biotechnology & Pharmaceuticals technology area. This current workload is part of a history of 11132 career applications. The firm has a resolved allowance rate of 80.67 percent, which measures the proportion of applications that reach a grant.
The prosecution process for this portfolio involves an average of 4.16 office actions per allowance. This figure is based on the firm's total volume of 11132 career applications and indicates the typical level of interaction required with the USPTO. The 295 pending office actions represent the current active matters being prosecuted.
With a resolved allowance rate of 80.67 percent, the firm demonstrates its ability to navigate the Biotechnology & Pharmaceuticals sector. These matters are handled within a framework that averages 4.16 office actions per allowance.
Based on the USPTO statutory response window for each pending office action. 106 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 106 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (1%) |
| §101 + other | 46 (13%) |
| §103 only | 87 (24%) |
| §102 only | 13 (4%) |
| §112 only | 27 (8%) |
| Double-patenting only | 11 (3%) |
| Double-patenting + other | 39 (11%) |
| Multi-statute (no §101) | 129 (36%) |
| No statute on record | 2 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SALMON, KATHERINE D | 5 | 42.8% | +37.9% |
| EBBINGHAUS, BRIANA NOEL | 3 | 59.2% | +62.7% |
| SU, STEPHANIE T | 3 | 67.1% | +28.5% |
| CHUNDURU, SURYAPRABHA | 3 | 53.3% | +17.8% |
| HINES, JANA A | 3 | 53.2% | +39.6% |
| MAHLUM, JONATHAN DAVIS | 3 | 50.0% | +26.7% |
| GOLDBERG, JEANINE ANNE | 3 | 45.5% | +40.6% |
| DABKOWSKI, ERINNE R | 3 | 55.8% | +68.8% |
| TRAN, LIEN THUY | 2 | 28.7% | +26.6% |
| ALLEN, MARIANNE P | 2 | 60.0% | +18.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17923671 | FLUID INJECTION DEVICE FOR INJECTING A FLUID BEHIND THE TYMPANIC MEMBRANE | DAVIS, JASON GREGORY | 167d overdue |
| 17920698 | INHIBITION OF SARS-COV-2 VIRAL ENTRY THROUGH ORAL ADMINISTRATION OF LACTOFERRIN AND USES THEREOF | BRADLEY, CHRISTINA | 162d overdue |
| 17768274 | COMPOUNDS FOR IMMUNOMODULATION | MIANO, JOSEPH PAUL | 146d overdue |
| 17906471 | T-CELL BISPECIFIC BINDING PROTEINS | OGUNBIYI, OLUWATOSIN A | 126d overdue |
| 17764850 | IgE Antibody with Fcgamma Receptor binding | SANG, HONG | 100d overdue |
| 17630568 | ELECTRONIC HAIL PAD | ISLAM, MOHAMMAD K | 89d overdue |
| 17929809 | METHODS AND SYSTEMS FOR PROCESSING TIME-RESOLVED SIGNAL INTENSITY DATA | CROW, ROBERT THOMAS | 51d overdue |
| 17549028 | PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE | ZHU, JIANJIAN | 44d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18425731 | PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS | HINES, JANA A | 119d overdue |
| 17727128 | DETECTING ESOPHAGEAL DISORDERS | GOLDBERG, JEANINE ANNE | 104d overdue |
| 18313856 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | DABKOWSKI, ERINNE R | 37d overdue |
| 18004082 | BIOMATERIAL COMPRISING BACTERIAL CELLULOSE AND PROBIOTICS AND USES THEREOF | HINES, JANA A | 36d overdue |
| 18245660 | METHODS AND COMPOSITIONS FOR REMOVAL OF RNA | SALMON, KATHERINE D | 5d overdue |
| 17266897 | TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS | DABKOWSKI, ERINNE R | 2d overdue |
| 19259540 | SLIDING BIOACTIVE PEPTIDES FOR THERAPEUTIC DELIVERY | ALLEN, MARIANNE P | 14d |
| 19426765 | PROCESS FOR PRODUCING BETA-LACTOGLOBULIN ISOLATES AND RELATED METHODS AND USES | TRAN, LIEN THUY | — |
| Art Unit | Apps |
|---|---|
| 1682 | 17 |
| 1681 | 9 |
| 1643 | 9 |
| 1683 | 8 |
| 1631 | 8 |
| 1632 | 7 |
| 1675 | 7 |
| 1641 | 7 |
| 1654 | 7 |
| 1672 | 6 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19426765 | PROCESS FOR PRODUCING BETA-LACTOGLOBULIN ISOLATES AND RELATED METHODS AND USES | Arla Foods Amba | TRAN, LIEN THUY | 1793 | §103§112DP | Non-Final OA | — | Pending | Dec 19, 2025 |
| 19374947 | COMPOSITIONS AND METHODS FOR OBTAINING HUMAN INTESTINAL TISSUE AND RELATED USES THEREOF | The Regents of the University of Michigan | BERTOGLIO, VALARIE E | 1632 | DP | Final Rejection | — | Pending | Oct 30, 2025 |
| 19161361 | PATIENT SUPPORT BOARD | Leo Cancer Care, Inc. | PATEL, TARLA R | 3786 | §102§103 | Non-Final OA | — | Pending | Sep 02, 2025 |
| 19271894 | PATIENT POSITIONING APPARATUS | Leo Cancer Care, Inc. | REMALY, MARK DONALD | §102§112 | Non-Final OA | — | Pending | Jul 17, 2025 | |
| 19259540 | SLIDING BIOACTIVE PEPTIDES FOR THERAPEUTIC DELIVERY | Northwestern University | ALLEN, MARIANNE P | 1647 | §102§103§112Other | Final Rejection | 14d | Pending | Jul 03, 2025 |
| 19259714 | HUMAN SPINAL CORD INJURY ORGANOIDS | Northwestern University | EBBINGHAUS, BRIANA NOEL | 1632 | §101§102§103§112DP | Non-Final OA | — | Pending | Jul 03, 2025 |
| 19233435 | LOCALIZED GENERATIVE ARTIFICIAL INTELLIGENCE FOR AUTONOMOUS DRIVING WITH WORLD MODEL | Cavh LLC | MARTINEZ BORRERO, LUIS A | Other | Non-Final OA | — | Pending | Jun 10, 2025 | |
| 19231650 | RESTORATION AND ELEVATION FOR VEHICLE DRIVING INTELLIGENCE | Cavh LLC | REDHEAD JR., ASHLEY L | §103 | Non-Final OA | — | Pending | Jun 09, 2025 | |
| 19226996 | ANASTOMOSIS FORMATION WITH MAGNETIC DEVICES HAVING TEMPORARY RETENTION MEMBER | Gt Metabolic Solutions, Inc. | DAVID, SHAUN L | 3771 | §103§112DP | Non-Final OA | — | Pending | Jun 03, 2025 |
| 19209521 | SYSTEMS AND METHODS FOR ASSESSING EJECTION FRACTION, HEART FAILURE, AND SLEEP APNEA USING ELECTROCARDIOGRAPHIC SIGNALS | Peerbridge Health, Inc. | MUTCHLER, CHRISTOPHER JOHN | §101§102§103§112 | Non-Final OA | — | Pending | May 15, 2025 | |
| 19128886 | COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING A DNA MODIFICATION | UMC Utrecht Holding B.V. | TOKARCZYK, CHRISTOPHER B | 3687 | §102§103§112 | Non-Final OA | — | Pending | May 09, 2025 |
| 19177062 | INCENTIVIZATION SYSTEMS FOR CURATION OF ARTIFICIAL INTELLIGENCE SYSTEMS | Evity Technologies, Inc. | PATEL, DIVESH | 3696 | §101§102§103 | Non-Final OA | — | Pending | Apr 11, 2025 |
| 19175167 | DEVICES AND METHODS FOR ASSISTING MAGNETIC COMPRESSION ANASTOMOSIS | Gt Metabolic Solutions, Inc. | TANNER, JOCELIN C | §102§103Other | Non-Final OA | — | Pending | Apr 10, 2025 | |
| 19119530 | KNITTED FABRIC AND ATTACHMENT USING SAID KNITTED FABRIC | Okamoto Corporation | HUANG, GRACE | 3732 | §102§103 | Final Rejection | — | Pending | Apr 09, 2025 |
| 19090669 | AUTOMATED DRIVING CLOUD SYSTEM FOR LONG-TAIL CORNER CASES | Cavh LLC | ISMAIL, MAHMOUD S | §112DP | Final Rejection | — | Pending | Mar 26, 2025 | |
| 19113074 | DUAL SCINTILLATOR SYSTEM FOR NEUTRON AND ELECTROMAGNETIC IMAGING | Shine Technologies, LLC | KAO, CHIH CHENG G | 2884 | §102§103§112 | Non-Final OA | — | Pending | Mar 19, 2025 |
| 19112886 | METHODS, DEVICES, AND SYSTEMS FOR TREATING BONE DEFECTS | The Regents of the University of Michigan | LAWSON, MATTHEW JAMES | 3619 | §102§103 | Non-Final OA | — | Pending | Mar 18, 2025 |
| 19111989 | FREQUENCY BASED RIG ANALYSIS | Exebenus AS | QUAIM, LAMIA | 3676 | §101§102 | Final Rejection | — | Pending | Mar 14, 2025 |
| 19108219 | PHOTOCLEAVAGE OF INDICAN | Danmarks Tekniske Universitet | KHAN, AMINA S | §101§102§103§112 | Non-Final OA | — | Pending | Mar 03, 2025 | |
| 19065311 | PROACTIVE SENSING SYSTEMS FOR AUTOMATED DRIVING SYSTEMS | Cavh LLC | POPE, DARYL C | DP | Non-Final OA | — | Pending | Feb 27, 2025 | |
| 19057621 | CLOUD-BASED AUTOMATED DRIVING SYSTEM FOR ADVERSE WEATHER CONDITIONS | Cavh LLC | EL CHANTI, HUSSEIN A | 3669 | DP | Final Rejection | — | Pending | Feb 19, 2025 |
| 19040053 | METHOD AND SYSTEM FOR EMERGENCY MONITORING AND ACTING IN DOMESTIC ENVIRONMENTS | Telefonica Innovacion Digital, S.L.U. | GARCIA, CARLOS E | 2686 | §101§102§103 | Final Rejection | — | Pending | Jan 29, 2025 |
| 18998013 | RECORD SUPPORT PLATE, RECORD JACKET, AND RECORD PRODUCT | P-Vine, Inc. | KLIMOWICZ, WILLIAM JOSEPH | 2688 | §102§103 | Non-Final OA | — | Pending | Jan 23, 2025 |
| 19030131 | SYSTEM AND METHOD FOR SINGLE MOLECULE DETECTION | Arizona Board of Regents | NOGUEROLA, ALEXANDER STEPHAN | §103§112Other | Non-Final OA | — | Pending | Jan 17, 2025 | |
| 19022747 | DEVICES AND METHODS FOR ASSISTING MAGNETIC COMPRESSION ANASTOMOSIS | Gt Metabolic Solutions, Inc. | TANNER, JOCELIN C | 3771 | §102 | Final Rejection | 78d overdue | Pending | Jan 15, 2025 |
| 19020225 | VEHICLE SAFETY SYSTEM FOR AUTONOMOUS DRIVING | Cavh LLC | SU, STEPHANIE T | 3662 | §103 | Final Rejection | — | Pending | Jan 14, 2025 |
| 18994414 | COMPOSITIONS AND METHODS FOR GROWING ESOPHAGEAL CELLS AND RELATED USES THEREOF | The Regents of the University of Michigan | MIANO, JOSEPH PAUL | §101§102§103§112 | Non-Final OA | — | Pending | Jan 14, 2025 | |
| 19019000 | VEHICLE-BASED CLOUD COMPUTING SYSTEM FOR AUTONOMOUS DRIVING | Cavh LLC | SU, STEPHANIE T | 3662 | §103 | Final Rejection | — | Pending | Jan 13, 2025 |
| 19016469 | NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF | BAYER AKTIENGESELLSCHAFT | RAMIREZ, DELIA M | 1652 | §102§103 | Non-Final OA | — | Pending | Jan 10, 2025 |
| 19012368 | COMPOSITIONS AND METHODS FOR OBTAINING VASCULARIZED HUMAN INTESTINAL ORGANOID TISSUE, AND RELATED USES THEREOF | The Regents of the University of Michigan | RAHMAN, MASUDUR | §112 | Non-Final OA | — | Pending | Jan 07, 2025 | |
| 19011131 | VEHICLE COMPUTING SYSTEM FOR AUTONOMOUS DRIVING | Cavh LLC | SU, STEPHANIE T | 3662 | §103§112 | Final Rejection | — | Pending | Jan 06, 2025 |
| 19008900 | BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS | UNIVERSITY OF MARYLAND, BALTIMORE | WAX, ROBERT A | §102§103§112 | Non-Final OA | — | Pending | Jan 03, 2025 | |
| 18990320 | SEPARABLE BI-DIRECTIONAL CHECK VALVE ASSEMBLY | Luminoah, Inc. | COLON MORALES, DAVID | 3753 | §103 | Final Rejection | 27d | Pending | Dec 20, 2024 |
| 18987112 | GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY | Abbott Laboratories | FARDANESH, MARJAN | §102 | Non-Final OA | — | Pending | Dec 19, 2024 | |
| 18984183 | GAS JET DEFLECTION IN PRESSURIZED SYSTEMS | Shine Technologies, LLC | WILLIAMS, JOSEPH L | §112 | Non-Final OA | — | Pending | Dec 17, 2024 | |
| 18873153 | OPTICAL ELEMENT | Osaka University | LAVARIAS, ARNEL C | 2872 | §102§103 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18971607 | LOW-DOSE TOCILIZUMAB FOR THE TREATMENT OR PREVENTION OF SICKLE CELL CRISIS | The University of Chicago | HADDAD, MAHER M | §103§112 | Non-Final OA | — | Pending | Dec 06, 2024 | |
| 18867262 | VANADYL SULFATE COMPOSITIONS AND METHODS OF USE THEREFOR FOR THE TREATEMENT AND PREVENTION OF AGING-RELATED DISEASES AND CANCER | The University of Chicago | CONIGLIO, AUDREA JUNE BUCKLEY | §103§112 | Non-Final OA | — | Pending | Nov 19, 2024 | |
| 18943512 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | Exact Sciences Corporation | BROWN, MINDY G | 1683 | §112 | Non-Final OA | 45d overdue | Pending | Nov 11, 2024 |
| 18941862 | BIOACTIVE AND ANTIOXIDANT SUPRAMOLECULAR POLYMER HYDROGELS FOR NEURAL CELL CULTURE | Northwestern University | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18939319 | TEMPERATURE-SELECTABLE FRET CASSETTE SIGNALING | Gen-Probe Incorporated | CHUNDURU, SURYAPRABHA | 1681 | §103 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18938794 | COMPOSITIONS AND METHODS RELATED TO SOMATIC EMBRYOGENESIS IN ROSE PLANTS | North Carolina State University | KAY, ZACHARIAH A | 1661 | §102§103§112 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18862189 | ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS | BURKETT, DANIEL JOHN | §102§112 | Non-Final OA | — | Pending | Nov 01, 2024 | |
| 18929268 | METHODS AND SYSTEMS RELATING TO ARTIFICIAL INTELLIGENCE FOR EARLY RECOGNITION OF RARE SKIN DISEASES | Northwestern University | BOYAR, NOAH WILLIAM | §101§103§112 | Non-Final OA | — | Pending | Oct 28, 2024 | |
| 18859007 | LIPIDS, FORMULATIONS, AND USES THEREOF | The Regents of the University of Michigan | CHANDRAKUMAR, NIZAL S | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2024 | |
| 18921114 | CUSTOMIZED, WEARABLE 3D PRINTED ARTICLES AND METHODS OF MANUFACTURING SAME | Printer Tailored, LLC | YANCHUS III, PAUL B | DP | Non-Final OA | — | Pending | Oct 21, 2024 | |
| 18919564 | USE OF MULTIPHOTON EXCITATION FOR FLUORESCENCE IMAGING OF STAINED CALCIFIED MINERALS | UNIVERSITY OF MARYLAND, BALTIMORE | MOSHER, ERIC PARKER | §103DP | Non-Final OA | — | Pending | Oct 18, 2024 | |
| 18852916 | TRANS-VACCENIC ACID (TVA) AND DERIVATIVES THEREOF IN T CELL-BASED CANCER THERAPIES | The University of Chicago | MCANANY, JOHN D | §102§103§112 | Non-Final OA | — | Pending | Sep 30, 2024 | |
| 18849659 | VEHICLE AND SERVER | Softbank Corp. | PALL, CHARLES J | 3663 | §103 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18884534 | ACIDIC BETA-LACTOGLOBULIN BEVERAGE PREPARATION | Arla Foods Amba | TAYLOR, AUSTIN PARKER | §103§112Other | Non-Final OA | — | Pending | Sep 13, 2024 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial80.7% of resolved applications prosecuted by Casimir Jones, S.C. were allowed, across 11,132 applications in USPTO records.
4.16 office actions per allowed application on average.
358 pending office actions as of October 2026, for 150 clients, before 296 examiners in 110 art units.